New Study: Big Pharma Hikes Prices Without Improving Their Drugs

Unjustified Price Increases Cost Patients And Health Plans Billions Big Pharma repeatedly hikes prices on brand name drugs without making any improvements to those medications. That’s the finding

10-8-2019 Read More

THEY SAID IT! HOUSE LAWMAKERS MAINTAIN COMMITMENT TO BIPARTISAN COOPERATION ON DRUG PRICING

House E&C Health Subcommittee Reiterate Need for Action to Hold Big Pharma Accountable, Deliver Relief for American Patients The U.S. House Energy and Commerce Subcommittee on Health held a

09-26-2019 Read More

ICYMI: An Unprecedented Opportunity for Washington to Lower Drug Prices

An Unprecedented Opportunity for Washington to Lower Drug Prices Lauren Aronson The Hill Congress was gaveled back into session this month with unprecedented momentum behind legislative efforts to

09-25-2019 Read More

CSRxP Urges E&C Lawmakers to Continue Building Bipartisan Consensus

Hearing on Drug Pricing Proposals an Opportunity for Focus on Areas of Agreement to Hold Big Pharma Accountable and Lower Drug Prices  For Immediate Release Contact: Jon Conradi 860-235-3884

09-23-2019 Read More

THEY SAID IT! LAWMAKERS SLAM BIG PHARMA FOR “GAMING THE SYSTEM” TO BLOCK COMPETITION

Members of E&C Consumer Protection Subcommittee Call for Bipartisan Action to Hold Brand Name Drug Makers Accountable   The U.S. House Energy & Commerce Subcommittee on Consumer

09-20-2019 Read More

CSRxP: House Rx Package Adds to Unprecedented Momentum to Hold Big Pharma Accountable

Speaker’s Drug Pricing Plan Includes Measures That Have Won Support from Both Sides of the Aisle For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. –

09-19-2019 Read More

CSRxP: HHS OIG REPORT DRASTICALLY UNDERCUTS BIG PHARMA’S BLAME GAME AT CRITICAL MOMENT IN WASHINGTON

Inspector General Finds Negotiated Rebates Slowed Medicare Part D Price Hikes, Saved Program $8 Billion on Drug Costs For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]

09-13-2019 Read More

NEW STUDY: BIG PHARMA PRICE-GOUGING MEDICATIONS FOR RARE DISEASES AT STAGGERING RATE

Orphan Drug Prices 25 Times More Expensive Than Traditional Drugs, AHIP Finds For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for

09-11-2019 Read More

Big Pharma Watch: Drug Maker Hit With $15 Million Penalty for Illegal Price Hike Scheme

In case you missed it, a recent article in HealthLeaders details how brand name drug maker Mallinckrodt used a foundation to secretly hike the price of the drug Acthar from $50 to $32,200 over a

09-10-2019 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.